CBCA News Alert Cannabis Capital Corp. (CBCA) 8.8000 09/28/2014

New Post Public Reply Private Reply Replies (0) Message Board

Sep 28, 2014 at 10:56 AM

Cannabis Capital Corp. (CBCA) 8.8000 $CBCA

Crown Baus Capital Corp (CBCA) Subsidiary WebCongress, Inc. Launches Major Tech Conference in Bogota, Colombia with Speakers from Microsoft, Google, Facebook
PR Newswire - Thu Aug 21, 1:08PM CDT
Crown Baus Capital Corp. (OTC: CBCA), a global acquisition-based conglomerate targeting five primary industries: high-tech incubation, drug development, entertainment/media, education, and financial services, announces the launch of WebCongress's most recent signature tech and social media conference in Bogota, Colombia today and tomorrow, August 21-22, 2014, one of many editions of WebCongress's power tech conferences presented in the Americas in 2014-2015.

Health & Wellness Industry Gets Excited by Recent Federal Medical Marijuana Legalization Efforts - Company Initiates Cannabis Drug Development Plan
PR Newswire - Fri Aug 01, 8:05AM CDT
Pharmaceutical, Wellness and Cannabis companies stand out in health sector with continual growth and significant acquisitions of resources: Crown Baus Capital Corp. (OTC: CBCA), Cannabis Sativa, Inc. (OTC: CBDS), GW Pharmaceuticals plc (NASDAQ: GWPH), Avalanche Biotechnologies Inc. (NASDAQ: AAVL) and Healthequity Inc. (NASDAQ: HQY)

Federal Medical Cannabis Legalization Efforts in Congress Motivates Crown Baus Capital to Initiate its Cannabis Drug Development Program With State-by-State Legal Resources
PR Newswire - Fri Aug 01, 7:00AM CDT
Crown Baus Capital Corp. (OTC: CBCA), a global acquisition-based conglomerate targeting five primary industries: high-tech incubation, drug development, entertainment/media, education, and financial services, sees this week's Congressional efforts to amend the Controlled Substances Act to permit medical use of cannabis on a nationwide basis as history in the making. This federal medical cannabis legalization effort in Congress motivates Crown Baus Capital to complete its negotiations to formally begin its Cannabis Drug Development Program using state-by-state legal resources and distribution.

Cannabis Drug Development Division of Crown Baus Capital Corp. (CBCA) is Motivated by the New York Times Editorial Board Position on 'Repealing Prohibition, Again'
PR Newswire - Tue Jul 29, 8:17AM CDT
Cannabis Capital Corp. (OTCBB: CBCA) is a global acquisition-based conglomerate targeting five primary industries: High-Tech Incubation, Drug Development, Entertainment/Media, Education, and Financial Services.

Crown Baus Capital (CBCA) Enhances Focus On Growing Incubation Business
ACCESSWIRE - Mon Jul 28, 7:41AM CDT
Boca Raton, FL / ACCESSWIRE / July 28, 2014 / Crown Baus Capital (OTCBB: CBCA), formerly called Cannabis Capital Corp., has bolstered its emphasis on global acquisition and business incubation, diversifying its already widening portfolio into some key areas. The Company recently received FINRA approval for the name change, while its symbol remains as CBCA.

Crown Baus Capital Receives FINRA Approval for Name Change, New CUSIP; Crown Baus Continues to Trade Under the Symbol CBCA
PR Newswire - Fri Jul 25, 8:28AM CDT
Cannabis Capital Corp. (OTCBB: CBCA) is a global acquisition-based conglomerate targeting five primary industries: High-Tech Incubation, Drug Development, Entertainment/Media, Education, and Financial Services. The Company is pleased to announce that yesterday, July 24, 2014 Crown Baus Capital Corp. (the "Company"

received approval from FINRA for its previously announced name change from Cannabis Capital Corp. (www.crownbaus.com )

Cannabis Capital reports change in name to better reflect corporate initiatives and long-term projects
M2 - Fri Jul 18, 9:51AM CDT
The board of directors of Cannabis Capital (OTC BB:CBCA) on Thursday approved a change in its name to Crown Baus Capital Corp, but expects no change in ticker symbol.

Cannabis Capital Corp. (CBCA) Changes Name to Crown Baus Capital Corp., Better Reflecting Corporate Initiatives and Long-term Projects
PR Newswire - Thu Jul 17, 7:16AM CDT
Cannabis Capital Corp. (OTCBB: CBCA) is a global acquisition-based conglomerate targeting five primary industries: High-Tech Incubation, Drug Development, Entertainment/Media, Education, and Financial Services. The Company is pleased to announce that its Board of Directors has selected the name Crown Baus Capital Corp. to better reflect the company's existing and prospective ventures in these five business sectors. Simultaneous with this announcement of the corporate name change, the Company's website www.crownbaus.com has been launched.

CBCA Subsidiary, WebCongress, Inc. is Proud to be an Official Live Stream Host of the Google I/O Developer Conference Underway June 25-26 in Miami, As Well, Live Stream is Available Globally via http://bit.ly/1lpIVLW
PR Newswire - Thu Jun 26, 8:45AM CDT
Cannabis Capital Corp. (OTC: CBCA) is an emerging global firm specializing in business development in high tech platforms, media and entertainment, pharmaceutical development, and medical technology. The Company is proud to announce that its subsidiary, WebCongress, Inc., is hosting the official Miami live streaming of the Google I/O Developer Conference. Again, tomorrow, for a second day WebCongress will host the Google I/O Live Stream through Venture Hive from 5-9 pm ET. The event will also be hosting developer sessions that will include Nest for Developers, Hack Your Glass and Predicting the Future with the Google Cloud Platform.

Cannabis Capital Corp. (CBCA) and WebCongress Getting In On Ground Floor of Google Inc. (GOOG)-Based Technologies
ACCESSWIRE - Mon Jun 16, 7:01AM CDT
Boca Raton, FL / June 16, 2014 / Investors looking for a considerably unique and progressive stock to add to their portfolio need look no further than Cannabis Capital Corp. (CBCA), a multi-faceted outfit specializing in business development and medical technology. CBCA's primary business ventures involve investment and development opportunities in the booming industry of legal marijuana and medical cannabis, both within the United States and worldwide.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

PASCAL's Holiday Gift Edit: Timeless Watches Shine

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Manhattan Associates Faces Investigation by KSF Law Firm

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

ManuTech Center Set to Revolutionize Manufacturing Hub

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

IEHP's Wellness Center Launch Faces Delay in California

Unexpected Delay for IEHP's Community Hub Straight outta Rancho Cucamonga, we've got some news that'll have folks in San Bernardino holding their breath a little longer. The Inland Empire Health Plan (or IEHP if you're part of the 1.4 million served by them) had folks pumped for their new Community Wellness Center. But guess what? They had to slam the brakes on the grand...

Dana Concludes Tender Offers for Senior Notes

By Hannah Lewis Updated Nov 13, 2026 Category News Views 151

An Investor's Glance at Dana's Strategic Moves Dana Incorporated (NYSE: DAN) just pulled a bold move with their tender offers, snapping up a hefty $357,873,000 in outstanding principal on their senior notes. This isn’t just pocket change; folks holding out for securities can feel the tension of watching big numbers get shuffled around. You gotta wonder, what's the play...

Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

HiTHIUM Joins Cambridge to Boost Global Energy Storage

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

MV Transportation Celebrates Leadership Nomination for FTA

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...